Department of Life Sciences;
Graduate School of Arts and Sciences;
The University of Tokyo;
Tokyo;
Japan;
Research Laboratories;
Chiome Bioscience Inc;
Tokyo;
Japan;
Immunoglobulin rearrangements; homologous recombination; antibody therapeutics; antibody engineering; drug discovery;